Moderna, Eli Lilly and Company, Hims & Hers Health, UnitedHealth Group, and Johnson & Johnson are the five Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly traded companies involved in healthcare, such as pharmaceutical and biotechnology firms, medical-device makers, hospitals, and health insurers. Investors may buy them to gain exposure to healthcare demand and innovation, while considering risks such as regulation, clinical-trial results, and policy changes. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.
Moderna (MRNA)
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines.
Shares of Moderna stock traded down $13.32 on Tuesday, hitting $255.68. The stock had a trading volume of 5,854,350 shares, compared to its average volume of 12,618,229. The stock has a 50 day moving average of $194.47 and a 200 day moving average of $92.61. Moderna has a twelve month low of $22.28 and a twelve month high of $280.80. The company has a debt-to-equity ratio of 0.09, a quick ratio of 2.18 and a current ratio of 2.29. The firm has a market capitalization of $102.08 billion, a P/E ratio of -36.09 and a beta of 1.16.
Read Our Latest Research Report on MRNA
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Shares of NYSE:LLY traded up $10.41 during mid-day trading on Tuesday, reaching $1,422.36. 964,454 shares of the company's stock were exchanged, compared to its average volume of 2,959,456. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.00 and a current ratio of 1.39. Eli Lilly and Company has a twelve month low of $850.51 and a twelve month high of $1,453.00. The firm has a market capitalization of $1.34 trillion, a price-to-earnings ratio of 46.21, a PEG ratio of 1.77 and a beta of 0.40. The business's fifty day moving average price is $1,220.13 and its 200-day moving average price is $1,102.83.
Read Our Latest Research Report on LLY
Hims & Hers Health (HIMS)
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
HIMS stock traded down $4.38 during trading on Tuesday, hitting $18.55. The company had a trading volume of 39,270,967 shares, compared to its average volume of 22,309,057. The stock has a market cap of $4.33 billion, a PE ratio of -29.36 and a beta of 2.53. The business has a 50-day moving average of $28.31 and a 200-day moving average of $26.91. The company has a current ratio of 0.93, a quick ratio of 0.87 and a debt-to-equity ratio of 4.21. Hims & Hers Health has a one year low of $13.74 and a one year high of $41.28.
Read Our Latest Research Report on HIMS
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Shares of UnitedHealth Group stock traded up $5.15 on Tuesday, hitting $402.77. 1,617,574 shares of the company's stock traded hands, compared to its average volume of 7,205,715. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78. The company has a market capitalization of $360.89 billion, a price-to-earnings ratio of 22.99, a price-to-earnings-growth ratio of 1.48 and a beta of 0.51. UnitedHealth Group has a one year low of $255.96 and a one year high of $461.62. The company has a fifty day moving average of $390.68 and a two-hundred day moving average of $364.28.
Read Our Latest Research Report on UNH
Johnson & Johnson (JNJ)
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.
Shares of NYSE JNJ traded down $0.84 during midday trading on Tuesday, reaching $281.26. The company's stock had a trading volume of 2,280,787 shares, compared to its average volume of 7,944,055. Johnson & Johnson has a 12-month low of $189.05 and a 12-month high of $283.25. The firm has a 50 day moving average price of $266.18 and a 200-day moving average price of $248.62. The stock has a market capitalization of $677.09 billion, a P/E ratio of 42.65, a PEG ratio of 2.73 and a beta of 0.22. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.02 and a quick ratio of 0.74.
Read Our Latest Research Report on JNJ
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Moderna, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Moderna wasn't on the list.
While Moderna currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
